T4	Effect 23 48	fulminant hepatic failure
T5	Subject 52 75	HIV-1-infected patients
T7	Treatment 89 105	didanosine (ddI)
T9	Severity_cue 23 32	fulminant
T10	Drug 89 99	didanosine
T11	Treat-Disorder 52 57	HIV-1
T8	Adverse_event 20 22	of
E1	Adverse_event:T8 
A1	Severity E1 High